| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.92▲ | 9.99▼ | 10.00▼ | 10.35▼ | 11.21▼ |
| MA10 | 9.93▲ | 10.01▼ | 10.04▼ | 10.56▼ | 11.18▼ |
| MA20 | 9.96▼ | 10.04▼ | 10.19▼ | 11.30▼ | 9.93▼ |
| MA50 | 10.03▼ | 10.32▼ | 10.48▼ | 11.33▼ | 9.57▲ |
| MA100 | 10.07▼ | 10.48▼ | 11.07▼ | 9.84▲ | 7.63▲ |
| MA200 | 10.31▼ | 11.32▼ | 11.05▼ | 9.88▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.005▲ | -0.003▼ | -0.189▼ | 0.020▲ |
| RSI | 48.582▼ | 39.671▼ | 37.054▼ | 38.239▼ | 49.315▼ |
| STOCH | 42.063 | 33.409 | 29.615 | 15.015▼ | 36.630 |
| WILL %R | -22.222▲ | -78.723▼ | -86.755▼ | -98.022▼ | -67.609 |
| CCI | 10.169 | -95.787 | -87.839 | -103.768▼ | -29.239 |
| ▼ BREAK | $ELTX Price Breaks 10 Days Low | Set Alert |
|
Wednesday, February 25, 2026 05:01 AM
BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...
|
|
Wednesday, February 18, 2026 12:00 AM
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 10.10 | 10.48 | 9.85 | 9.91 | 105,051 |
| 07/05/26 | 10.45 | 11.00 | 9.89 | 10.01 | 137,496 |
| 06/05/26 | 10.69 | 10.69 | 10.289 | 10.45 | 97,060 |
| 05/05/26 | 10.92 | 11.215 | 10.41 | 10.59 | 89,599 |
| 04/05/26 | 10.77 | 11.07 | 10.65 | 10.77 | 105,413 |
| 01/05/26 | 10.60 | 11.0199 | 10.445 | 10.75 | 92,723 |
| 30/04/26 | 10.39 | 10.635 | 10.125 | 10.62 | 119,001 |
| 29/04/26 | 10.80 | 10.80 | 10.23 | 10.32 | 127,466 |
| 28/04/26 | 11.29 | 11.45 | 10.71 | 10.80 | 95,411 |
| 27/04/26 | 11.74 | 12.5499 | 10.76 | 11.36 | 262,513 |
|
|
||||
|
|
||||
|
|